AmerisourceBergen Corporation (ABC)
| Market Cap | 21.47B |
| Revenue (ttm) | 189.89B |
| Net Income (ttm) | -3.41B |
| Shares Out | 204.78M |
| EPS (ttm) | -16.65 |
| PE Ratio | n/a |
| Forward PE | 12.36 |
| Dividend | $1.76 |
| Dividend Yield | 1.63% |
| Trading Day | January 22 |
| Last Price | $107.76 |
| Previous Close | $104.91 |
| Change ($) | 2.85 |
| Change (%) | 2.72% |
| Day's Open | 104.66 |
| Day's Range | 104.66 - 108.72 |
| Day's Volume | 1,595,379 |
| 52-Week Range | 72.96 - 110.13 |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March...
AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership.
Walgreens Boots Alliance Inc (NASDAQ: WBA) disclosed on Wednesday that it had signed an agreement with healthcare products distributor AmerisourceBergen Corp (NYSE: ABC) to sell a majority sta...
In an announcement on Wednesday, Walgreens Boots Alliance Inc (NASDAQ: WBA) said it will sell its distribution business to AmerisourceBergen Corp (NYSE: ABC) for £4.78 billion. Walgreens share...
The shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) are up 2.5% to trade at $42.18 this morning, after it was reported that the company is selling its Alliance Healthcare businesses to Am...
The large drug wholesaler AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's “Alliance Healthcare business” for $6.5 billion, the companies announced Wednesday.
AmerisourceBergen also raised its guidance, sending shares up more than 6% in early Wednesday trade
Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today updated its fiscal year 2021 financial guidance to reflect the Company's continued strong operating income p...
VALLEY FORGE, Pa. & DEERFIELD, Ill.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) and Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced strategic agreements under whic...
AmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth. The company does have a deal with the CDC to handle the distribution of COVID vaccin...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2021 on Thursday, February 4,...
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
Let's see if AmerisourceBergen (ABC) stock is a good choice for value-oriented investors right now from multiple angles.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--As part of its commitment to fostering a diverse and inclusive culture, AmerisourceBergen, a global healthcare solutions leader, announced the appointment o...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Prov...
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 2020 Results - Earnings Call Transcript
AmerisourceBergen's (ABC) fiscal fourth-quarter results benefit from segmental growth.
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.07% and 2.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent ...
AmerisourceBergen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. The post AmerisourceBergen Shares Pop Amid Strong 2020 Growth; Earnings Due As It Gets...
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking ...
AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
The pandemic is out of control all over the world, with daily records in new cases and a mounting death toll. Europe is beginning to lock down again and IHME expects up to 20 US states to foll...
AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen kicked off its first-ever ThinkLive Trade virtual event, a three-day online summit geared toward brand, specialty and generic manuf...
ABC is one of the largest global healthcare distribution companies. By distributing brand name, specialty brand name, and generic products to customers, ABC has one of the most diverse product...
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into October of 2020.
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter Fiscal 2020 on Thursday, November 5, 2...
As the world grapples with an unprecedented coronavirus pandemic, five health care stocks that have outperformed the Standard & Poor's 500 Index by at least 5% in the year to date are Amerisou...
The current stock market is still expensive by historical standards, but deals do occasionally appear.
Stocks include a new addition to the gurus' list of good companies
Looking to trade using volume? Have a look at these essential tips.
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. However, stiff competition remains a woe.
September 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
AmerisourceBergen: The Highest Quality Healthcare Company On Sale
Stocks have made a remarkable (and remarkably rapid) recovery from the 2020 bear market.
2020 has been great for growth stocks. But as markets reach premium valuations, consider these seven value stocks to buy for peace of mind.
Producer Johnson & Johnson, and distributors McKesson, AmerisourceBergen, and Cardinal Health will all be expected to contribute to the settlement.
States are asking pharmaceutical companies to pay $26.4 billion for opioid crisis: Report
Yahoo Finance’s Alexis Keenan joins The First Trade with Alexis Christoforous and Brian Sozzi to discuss U.S. states asking pharmaceutical giants, including AmerisourceBergen, Cardinal Health,...
About ABC
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alter... [Read more...]
| Industry Medical Distribution | IPO Date Apr 4, 1995 |
| CEO Steven Collis | Employees 21,000 |
| Stock Exchange NYSE | Ticker Symbol ABC |
Analyst Forecasts
According to 19 analysts, the average rating for ABC stock is "Buy." The 12-month stock price forecast is 121.13, which is an increase of 12.41% from the latest price.